Related references
Note: Only part of the references are listed.Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody
Kevin J. H. Allen et al.
PHARMACEUTICALS (2023)
Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models
Jaline Broqueza et al.
PHARMACEUTICALS (2022)
Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma
Jaline Broqueza et al.
CANCERS (2021)
Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik et al.
NATURE (2020)
Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody-Drug Conjugate Via Fc-FcγR Interaction
Fu Li et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Mechanisms Influencing the Pharmacokinetics and Disposition of Monoclonal Antibodies and Peptides
Amita Datta-Mannan
DRUG METABOLISM AND DISPOSITION (2019)
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases
Oliver Sartor et al.
PROSTATE (2019)
Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins
Takashi Takeda et al.
CELL DEATH & DISEASE (2019)
An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence
Chang-Han Lee et al.
NATURE COMMUNICATIONS (2019)
Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors
Sharayu Karkare et al.
SCIENTIFIC REPORTS (2019)
Transient expression of human antibodies in mammalian cells
Rodrigo Vazquez-Lombardi et al.
NATURE PROTOCOLS (2018)
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
Liming Liu
PROTEIN & CELL (2018)
Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models
Sai Kiran Sharma et al.
CANCER RESEARCH (2018)
Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes
Mauro Cataldi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Outcome and complications in dogs with appendicular primary bone tumors treated with stereotactic radiotherapy and concurrent surgical stabilization
Sarah E. Boston et al.
VETERINARY SURGERY (2017)
Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics
Siobhan Simpson et al.
ACTA VETERINARIA SCANDINAVICA (2017)
Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)
David S. Geller et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Targeting FcRn for the modulation of antibody dynamics
E. Sally Ward et al.
MOLECULAR IMMUNOLOGY (2015)
Radioimmunotherapy of human tumours
Steven M. Larson et al.
NATURE REVIEWS CANCER (2015)
Stereotactic Radiosurgery and Fracture Fixation in 6 Dogs With Appendicular Osteosarcoma
Jennifer L. Covey et al.
VETERINARY SURGERY (2014)
A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
Gabriel J. Robbie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Cell surface receptor expression patterns in osteosarcoma
Sheref E. Hassan et al.
CANCER (2012)
Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006)
Dianna E. Saam et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2011)
Dog models of naturally occurring cancer
Jennie L. Rowell et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Biology, diagnosis and treatment of canine appendicular osteosarcoma: Similarities and differences with human osteosarcoma
Emanuela Morello et al.
VETERINARY JOURNAL (2011)
Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis
Irena Martin-Kleiner et al.
CANCER LETTERS (2010)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Cation-independent Mannose 6-Phosphate Receptor A COMPOSITE OF DISTINCT PHOSPHOMANNOSYL BINDING SITES
Richard N. Bohnsack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Use of Single-Agent Carboplatin as Adjuvant or Neoadjuvant Therapy in Conjunction With Amputation for Appendicular Osteosarcoma in Dogs
Brenda Philips et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2009)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs
JP Farese et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2004)
Antibody-targeted radiation cancer therapy
DE Milenic et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Share Paper
